Berlin I, Cournot A, Zimmer R, Pedarriosse A M, Manfredi R, Molinier P, Puech A J
Département de Pharmacologie Clinique, Hôpital Pitié-Salpêtrière, Paris, France.
Psychopharmacology (Berl). 1990;100(1):40-5. doi: 10.1007/BF02245787.
The interaction of clomipramine and moclobemide with alcohol was compared in a double blind parallel groups study in 24 healthy volunteers. Moclobemide was given at the highest recommended therapeutic dose (200 mg t.i.d.) and clomipramine in a subtherapeutic dose (25 mg b.i.d.) because of its poor tolerance in healthy subjects. Psychometric evaluations were performed during a placebo run-in phase; after a 5-day treatment period; assessments were made before, and again 1 h and 4 h after alcohol ingestion. Alcohol doses were pre-determined for each subject in order to produce a blood alcohol concentration of 0.6 g/l 1 h after alcohol intake and this individual alcohol dose was given on test days. The day before alcohol intake tests for autonomic functions were made to assess the anticholinergic effects of the drugs. Alcohol significantly increased body sway, decreased critical flicker fusion frequency, prolonged choice reaction time, impaired copying skills, impaired memory and increased the subjective feelings of satisfaction and tension. Drugs increased the effect of alcohol on body sway and this was essentially due to clomipramine. Clomipramine both without and with alcohol increased body sway, prolonged choice reaction time more than did moclobemide. Clomipramine seemed to diminish alcohol-induced memory impairment in one of the memory tests used. Subjects taking clomipramine had significantly more adverse effects after alcohol ingestion than did subjects of the moclobemide group. In contrast to moclobemide, clomipramine produced a moderate but significant drop in standing systolic blood pressure and a clear inhibition of salivary excretion.(ABSTRACT TRUNCATED AT 250 WORDS)
在一项针对24名健康志愿者的双盲平行组研究中,比较了氯米帕明和吗氯贝胺与酒精的相互作用。由于氯米帕明在健康受试者中耐受性较差,因此给予其低于治疗剂量(每日两次,每次25毫克),而给予吗氯贝胺最高推荐治疗剂量(每日三次,每次200毫克)。在安慰剂导入期进行心理测量评估;经过5天的治疗期后,在饮酒前、饮酒后1小时和4小时再次进行评估。为每个受试者预先确定酒精剂量,以便在饮酒后1小时产生0.6克/升的血液酒精浓度,并在测试日给予该个体酒精剂量。在饮酒前一天进行自主神经功能测试,以评估药物的抗胆碱能作用。酒精显著增加身体摇摆、降低临界闪烁融合频率、延长选择反应时间、损害抄写技能、损害记忆力,并增加主观的满足感和紧张感。药物增强了酒精对身体摇摆的影响,这主要归因于氯米帕明。无论是否与酒精同时服用,氯米帕明都会增加身体摇摆,比吗氯贝胺更能延长选择反应时间。在所用的一项记忆测试中,氯米帕明似乎减轻了酒精引起的记忆损害。与吗氯贝胺组的受试者相比,服用氯米帕明的受试者在饮酒后出现的不良反应明显更多。与吗氯贝胺不同,氯米帕明使站立时收缩压适度但显著下降,并明显抑制唾液分泌。(摘要截断于250字)